Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solitary Kidney”

1,472 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,472 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT01265368
What this trial is testing

A Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine in Patients With Advanced Renal Cell Carcinoma (ASET)

Who this might be right for
Stage IV Renal Cell Cancer
Mologen AG 19
Early research (Phase 1)Study completedNCT01424176
What this trial is testing

Dexpramipexole Renal PK Study

Who this might be right for
Amyotrophic Lateral SclerosisRenal Insufficiency
Knopp Biosciences 36
Not applicableUnknownNCT04540640
What this trial is testing

Oxygenated Machine Preservation in Kidney Transplantation

Who this might be right for
Kidney Transplantation
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 15
Early research (Phase 1)Study completedNCT00824590
What this trial is testing

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 20
Large-scale testing (Phase 3)Study completedNCT00517413
What this trial is testing

LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.

Who this might be right for
Anemia
Hoffmann-La Roche 163
Testing effectiveness (Phase 2)Study completedNCT02335918
What this trial is testing

A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Ovarian Carcinoma-Enrollment CompletedColorectal Cancer (CRC)-Enrollment Completed+2 more
Celldex Therapeutics 175
Early research (Phase 1)Study completedNCT05324410
What this trial is testing

Dose Escalation Study to Evaluate Safety and Pharmacokinetics (PK) of VX-840 in Healthy Participants

Who this might be right for
APOL1-mediated Kidney Disease
Vertex Pharmaceuticals Incorporated 88
Large-scale testing (Phase 3)Looking for participantsNCT03969329
What this trial is testing

Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

Who this might be right for
Secondary Hyperparathyroidism
Amgen 24
Early research (Phase 1)Not Yet RecruitingNCT07143331
What this trial is testing

Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers

Who this might be right for
Healthy ParticipantsAlzheimer DiseaseChronic Kidney Disease
Klotho Sciences Australia Pty Ltd. 84
Testing effectiveness (Phase 2)Ended earlyNCT06716853
What this trial is testing

A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma

Who this might be right for
Clear Cell RCC
Genenta Science 10
Early research (Phase 1)Ended earlyNCT05061537
What this trial is testing

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Renal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more
Pfizer 13
Post-approval studies (Phase 4)Study completedNCT00374803
What this trial is testing

Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal

Who this might be right for
End Stage Renal Disease (ESRD)
University of Cincinnati 45
Early research (Phase 1)Study completedNCT06559527
What this trial is testing

A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function

Who this might be right for
Diabetes Mellitus, Type 2ObesityOverweight
Novo Nordisk A/S 42
Early research (Phase 1)Study completedNCT02894905
What this trial is testing

Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335

Who this might be right for
Renal Insufficiency
Janssen Research & Development, LLC 24
Large-scale testing (Phase 3)Study completedNCT00005966
What this trial is testing

Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)Ended earlyNCT04678505
What this trial is testing

Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)

Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 9
Early research (Phase 1)Study completedNCT06715670
What this trial is testing

Investigate the Blood Concentrations of 4 Different Oral Doses of Zibotentan in Healthy Non-Asian and Japanese Participants

Who this might be right for
Liver Cirrhosis
AstraZeneca 30
Early research (Phase 1)Study completedNCT06527677
What this trial is testing

Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects

Who this might be right for
Renal Impairment
Antabio 41
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Next Page